CN107698651B - 一种高纯度度他雄胺的生产工艺 - Google Patents
一种高纯度度他雄胺的生产工艺 Download PDFInfo
- Publication number
- CN107698651B CN107698651B CN201710848537.7A CN201710848537A CN107698651B CN 107698651 B CN107698651 B CN 107698651B CN 201710848537 A CN201710848537 A CN 201710848537A CN 107698651 B CN107698651 B CN 107698651B
- Authority
- CN
- China
- Prior art keywords
- dutasteride
- filter cake
- water
- hours
- cooled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- JWJOTENAMICLJG-QWBYCMEYSA-N dutasteride Chemical compound O=C([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)N[C@@H]4CC3)C)CC[C@@]21C)NC1=CC(C(F)(F)F)=CC=C1C(F)(F)F JWJOTENAMICLJG-QWBYCMEYSA-N 0.000 title claims abstract description 79
- 229960004199 dutasteride Drugs 0.000 title claims abstract description 78
- 238000004519 manufacturing process Methods 0.000 title abstract description 10
- 239000012043 crude product Substances 0.000 claims abstract description 31
- 238000002360 preparation method Methods 0.000 claims abstract description 31
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 105
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 69
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 66
- 239000012065 filter cake Substances 0.000 claims description 63
- 238000006243 chemical reaction Methods 0.000 claims description 62
- 238000003756 stirring Methods 0.000 claims description 46
- 238000001914 filtration Methods 0.000 claims description 44
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 43
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 42
- 235000019441 ethanol Nutrition 0.000 claims description 35
- 239000007787 solid Substances 0.000 claims description 30
- 239000002253 acid Substances 0.000 claims description 28
- 150000003839 salts Chemical class 0.000 claims description 28
- 238000002425 crystallisation Methods 0.000 claims description 27
- 230000008025 crystallization Effects 0.000 claims description 27
- 239000003480 eluent Substances 0.000 claims description 19
- -1 drains Substances 0.000 claims description 16
- XWMVIJUAZAEWIE-UHFFFAOYSA-N 2,5-bis(trifluoromethyl)aniline Chemical compound NC1=CC(C(F)(F)F)=CC=C1C(F)(F)F XWMVIJUAZAEWIE-UHFFFAOYSA-N 0.000 claims description 15
- 238000005406 washing Methods 0.000 claims description 14
- 238000010792 warming Methods 0.000 claims description 13
- 238000004587 chromatography analysis Methods 0.000 claims description 12
- 239000000919 ceramic Substances 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 11
- 239000012528 membrane Substances 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 10
- 238000010583 slow cooling Methods 0.000 claims description 10
- 238000009413 insulation Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims description 6
- 206010013786 Dry skin Diseases 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 4
- 230000006837 decompression Effects 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- 230000000630 rising effect Effects 0.000 claims description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Substances OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 2
- XPDWGBQVDMORPB-UHFFFAOYSA-N Fluoroform Chemical compound FC(F)F XPDWGBQVDMORPB-UHFFFAOYSA-N 0.000 claims 2
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 17
- 239000000047 product Substances 0.000 abstract description 16
- 238000000746 purification Methods 0.000 abstract description 6
- 239000012535 impurity Substances 0.000 abstract description 2
- 239000002904 solvent Substances 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000011347 resin Substances 0.000 description 8
- 229920005989 resin Polymers 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 3
- 231100000360 alopecia Toxicity 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- HDVRLUFGYQYLFJ-UHFFFAOYSA-N flamenol Chemical compound COC1=CC(O)=CC(O)=C1 HDVRLUFGYQYLFJ-UHFFFAOYSA-N 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- 229910019020 PtO2 Inorganic materials 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940054749 avodart Drugs 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001805 chlorine compounds Chemical group 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 125000005909 ethyl alcohol group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
实验方案 | 收率(%) | 纯度(%) |
方案1 | 52.60 | 96.58 |
方案2 | 62.53 | 97.27 |
方案3 | 71.43% | 97.82 |
方案4 | 85.37% | 98.35 |
方案5 | 87.98% | 99.75 |
方案6 | 88.21% | 99.85 |
陶瓷膜孔径 | 收率(%) | 纯度(%) |
0.20μ | 52.32 | 99.95 |
0.30μ | 62.75 | 99.92 |
0.45μ | 88.21 | 99.85 |
0.60μ | 87.96 | 98.52 |
1μ | 85.87 | 95.30 |
2μ | 80.75 | 85.12 |
树脂型号 | 颗粒直径 | 均匀度(%) | 收率(%) | 纯度(%) |
D-101 | 50~100 | ≥95 | 88.32 | 99.83 |
D-101 | >100 | ≥95 | 87.54 | 98.52 |
D-101 | >100 | <95 | 85.62 | 97.35 |
D-103 | 50~100 | ≥95 | 88.20 | 99.81 |
D-103 | >100 | ≥95 | 87.15 | 98.35 |
D-103 | >100 | <95 | 84.98 | 96.95 |
BS-75 | 50~100 | ≥95 | 88.12 | 99.75 |
BS-75 | 50~100 | <95 | 86.95 | 98.33 |
BS-75 | >100 | <95 | 84.57 | 96.78 |
HZ-802 | 50~100 | ≥95 | 62.14 | 65.78 |
HZ-802 | 50~100 | <95 | 60.75 | 62.48 |
HZ-802 | >100 | <95 | 55.73 | 59.85 |
AB-8 | 50~100 | ≥95 | 45.37 | 67.23 |
AB-8 | 50~100 | <95 | 44.58 | 60.29 |
AB-8 | >100 | <95 | 35.78 | 55.36 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710848537.7A CN107698651B (zh) | 2017-09-19 | 2017-09-19 | 一种高纯度度他雄胺的生产工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710848537.7A CN107698651B (zh) | 2017-09-19 | 2017-09-19 | 一种高纯度度他雄胺的生产工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107698651A CN107698651A (zh) | 2018-02-16 |
CN107698651B true CN107698651B (zh) | 2018-11-13 |
Family
ID=61172967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710848537.7A Active CN107698651B (zh) | 2017-09-19 | 2017-09-19 | 一种高纯度度他雄胺的生产工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107698651B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109270178B (zh) * | 2018-09-10 | 2021-06-29 | 重庆华邦制药有限公司 | 一种高效液相色谱法分离测定度他雄胺软胶囊中度他雄胺及有关物质的方法 |
CN110950923B (zh) * | 2019-12-31 | 2022-12-23 | 湖北葛店人福药业有限责任公司 | 一种从度他雄胺母液物中回收度他雄胺的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012035553A1 (en) * | 2010-09-15 | 2012-03-22 | Ind-Swift Laboratories Limited | Process for preparing androstenone derivatives |
CN103539830B (zh) * | 2013-06-30 | 2018-08-31 | 北京万全德众医药生物技术有限公司 | 一种制备度他雄胺的方法 |
CN105646641A (zh) * | 2016-02-26 | 2016-06-08 | 赵建华 | 非那雄胺和度他雄胺合成中1,2位双键的形成方法 |
-
2017
- 2017-09-19 CN CN201710848537.7A patent/CN107698651B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN107698651A (zh) | 2018-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106866553A (zh) | 一种法匹拉韦的合成方法 | |
CN108558747A (zh) | 一种瑞戈非尼的制备方法 | |
CN107698651B (zh) | 一种高纯度度他雄胺的生产工艺 | |
CN105085388A (zh) | 一种索拉非尼中间体的合成方法 | |
CN106699570A (zh) | (2‑氯‑5‑碘苯基)(4‑氟苯基)甲酮的合成方法 | |
CN106565627A (zh) | 一种非布司他药用晶型的制备方法 | |
CN103012290B (zh) | 一种高纯度吉非替尼的制备方法 | |
CN107573264A (zh) | 一种3‑氰基‑5‑甲氧基苯‑1‑磺酰氯的制备工艺 | |
CN108276414B (zh) | 一种枸橼酸托法替尼的制备方法 | |
CN104910067A (zh) | 一锅法合成瑞戈非尼的方法 | |
CN104086545A (zh) | 1-(2-氟苄基)-1H-吡唑并[3,4-b]吡啶-3-甲脒盐酸盐的合成方法 | |
CN107298678B (zh) | 一种原料药苏沃雷生的制备方法 | |
CN105037186A (zh) | 一种氨甲苯酸的制备方法 | |
CN102127081B (zh) | 一种腺嘌呤的制备方法 | |
CN103159620A (zh) | 一种2-羟基间苯二甲酸的制备方法 | |
CN108997209A (zh) | 一种瑞戈非尼的制备方法 | |
CN107383418B (zh) | 一种抗紫外线塑料添加剂及其制备方法 | |
CN104592122A (zh) | 3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺的制备方法 | |
CN101899046B (zh) | 合成潘生丁中间体——2,4,6,8-四羟基嘧啶并[5,4-d]嘧啶的方法 | |
CN103396323A (zh) | 一种盐酸溴己新的生产方法 | |
CN112898277B (zh) | 一种阿法替尼中间体的制备方法 | |
CN108409648B (zh) | 一种甲苯磺酸索拉非尼相关中间体的制备方法 | |
CN102911125A (zh) | 一种吉非替尼中间体的制备方法 | |
CN107915694A (zh) | 1‑[2‑(2,4‑二甲基苯基巯基)苯基]哌嗪盐酸盐及其制备方法 | |
CN102329317B (zh) | 一种可可碱的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Production process of high purity tasandramine Effective date of registration: 20211223 Granted publication date: 20181113 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: JIANGXI JEMINCARE GROUP Co.,Ltd. Registration number: Y2021980016166 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220902 Granted publication date: 20181113 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: JIANGXI JEMINCARE GROUP Co.,Ltd. Registration number: Y2021980016166 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A kind of production process of high-purity Tasteride Effective date of registration: 20220905 Granted publication date: 20181113 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: JIANGXI JEMINCARE GROUP Co.,Ltd. Registration number: Y2022980014583 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230830 Granted publication date: 20181113 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: JIANGXI JEMINCARE GROUP Co.,Ltd. Registration number: Y2022980014583 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Production Process of High Purity Tadrosterone Effective date of registration: 20230831 Granted publication date: 20181113 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: JIANGXI JEMINCARE GROUP Co.,Ltd. Registration number: Y2023980054957 |